Tizianel, I.; Beber, A.; Madinelli, A.; Caccese, M.; Barollo, S.; Bertazza, L.; Ruggiero, E.; Censi, S.; Mian, C.; Ceccato, F.
Mitotane-Induced Hypothyroidism and Dyslipidemia in Adrenocortical Carcinoma: Sex Differences and Novel Evidence from a Thyroid Cell Model. Curr. Oncol. 2025, 32, 700.
https://doi.org/10.3390/curroncol32120700
AMA Style
Tizianel I, Beber A, Madinelli A, Caccese M, Barollo S, Bertazza L, Ruggiero E, Censi S, Mian C, Ceccato F.
Mitotane-Induced Hypothyroidism and Dyslipidemia in Adrenocortical Carcinoma: Sex Differences and Novel Evidence from a Thyroid Cell Model. Current Oncology. 2025; 32(12):700.
https://doi.org/10.3390/curroncol32120700
Chicago/Turabian Style
Tizianel, Irene, Arianna Beber, Alberto Madinelli, Mario Caccese, Susi Barollo, Loris Bertazza, Elena Ruggiero, Simona Censi, Caterina Mian, and Filippo Ceccato.
2025. "Mitotane-Induced Hypothyroidism and Dyslipidemia in Adrenocortical Carcinoma: Sex Differences and Novel Evidence from a Thyroid Cell Model" Current Oncology 32, no. 12: 700.
https://doi.org/10.3390/curroncol32120700
APA Style
Tizianel, I., Beber, A., Madinelli, A., Caccese, M., Barollo, S., Bertazza, L., Ruggiero, E., Censi, S., Mian, C., & Ceccato, F.
(2025). Mitotane-Induced Hypothyroidism and Dyslipidemia in Adrenocortical Carcinoma: Sex Differences and Novel Evidence from a Thyroid Cell Model. Current Oncology, 32(12), 700.
https://doi.org/10.3390/curroncol32120700
